MSK researchers are helping to map the landscape of viruses that infect us all, and to analyze the impact they have on human health and disease.

MSK experts believe that giving the targeted drug asciminib to patients with chronic myeloid leukemia at the beginning of ...

The Memorial Sloan Kettering Cancer Center (MSK) community extends our congratulations to Board of Trustees member David M. Rubenstein, who received the Presidential Medal of Freedom — the nation’s ...

A research team at Memorial Sloan Kettering Cancer Center (MSK) has made new insights into how the body forms immune cell ...

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ancestries, according to new MSK research. This trend could exacerbate ...

The immune system responds to viral infections by introducing a complex interplay of immune cells and factors, whose goal is to eliminate the intruding pathogen. One such effector cell in the ...

Our laboratory uses a combination of structural biology and biophysical techniques to discover how ion channels and membrane-embedded enzymes function at the atomic level. The proteins we study are ...

The goal of our laboratory is to understand when, why, and how immune cells become unresponsive to tumors or self-destructive in autoimmune diseases. We develop genetic cancer mouse models that mimic ...

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

Research at MSK Our research impact Research topics Core facilities & resources ...

Kimberly Feigin, MD, has been named Chief of the Breast Imaging Service within the Department of Radiology. Dr. Feigin has been a member of the service for 22 years and most recently served as Interim ...

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.